FGF21 and diabetes mellitus: Besides those insulin-mimetic properties, FGF21 does not induce mitogenicity, hypoglycaemia or weight gain at any dose tested in diabetic or healthy animals or when overexpressed in transgenic mice 13; therefore, FGF21 shows a promise as an effective treatment of diabetes.